Binnicker Matthew J, Espy Mark J, Irish Cole L, Vetter Emily A
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
J Clin Microbiol. 2015 Jul;53(7):2353-4. doi: 10.1128/JCM.00791-15. Epub 2015 Apr 29.
We compared an FDA-cleared rapid (<20 min) PCR assay (Cobas Liat; Roche Diagnostics) to our routine influenza A and B real-time PCR assay (Simplexa Flu A/B & RSV Direct; Focus Diagnostics) using respiratory swabs (n = 197). The Cobas Liat influenza A and B assays demonstrated sensitivities of 99.2% (123/124) and 100% (23/23), respectively, while showing a specificity of 100% for each target.
我们使用呼吸道拭子(n = 197),将一种经美国食品药品监督管理局(FDA)批准的快速(<20分钟)聚合酶链反应(PCR)检测方法(Cobas Liat;罗氏诊断公司)与我们常规的甲型和乙型流感实时PCR检测方法(Simplexa Flu A/B & RSV Direct;Focus诊断公司)进行了比较。Cobas Liat甲型和乙型流感检测方法的敏感性分别为99.2%(123/124)和100%(23/23),而对每个靶点的特异性均为100%。